We found that among sarcoma and renal cell carcinoma patients diagnosed with a hereditary cancer susceptibility syndrome, the prevalence of a germline ATM pathogenic variant was 2.4% and 6.5%, respectively. The gene discussed is ATM; the disease is sarcoma.